reference/20358806

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20358806

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Clinical Trial, Phase II\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
issn	1757-6512
issueIdentifier	1
pageRange	244-
publicationName	Stem Cell Research & Therapy
startingPage	244
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c7b74cfc2c7e643b16416c4eb5eda1e5 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a71960533e57bbfecb38e66869a95032 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_089ec853871a3584ca4f2860172d2dad http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d813a34c1e4381504d2b075a53f74917 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_fd178558489f960a69b0303d825b897c http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_71c03220b2f93c803b7d1a088d11ea63 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4e570e7892a4a6d9434d2a0fd8cde1ee http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e053629a4ad99f3a4ea04b7812e18365
bibliographicCitation	Zhang Y, Zhang J, Yi H, Zheng J, Cai J, Chen W, Lu T, Chen L, Du C, Liu J, Yao J, Zhao H, Wang G, Fu B, Zhang T, Zhang J, Wang G, Li H, Xiang AP, Chen G, Yi S, Zhang Q, Yang Y. A novel MSC-based immune induction strategy for ABO-incompatible liver transplantation: a phase I/II randomized, open-label, controlled trial. Stem Cell Research & Therapy. 2021 Apr 16;12(1):244. doi: 10.1186/s13287-021-02246-4.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58f665e0315c14f80b6d516ef36c83a5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_661b040592ed5cb089b0cae4592b4807 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_032064914ee9fd7e8d74566f055bb797 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ffe21c93402f5bc46607fd1af9121424 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1f8b3e5468794393032e21fefba2fea5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e946ff2f73dd6716779b5b182d8f83c6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9bb6f6a455ed776ce1edbf8009aa4329 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_33944fee2bf8ab01a2e7f67d88482237 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_840554fd804bcf7f3b216d8999d37ed2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_36cc39cb6c88004445b9a5fe2c34321a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4636d1eba30157fb6dd0c55589801bbf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_080ebb410d0a80f34dff0e7d7b4c522c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fdd5ab4dddc8563d9dfae07c5af61642 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_22466b7676bf2fe5578b02f121826faf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32cd9c0beab80785455c38764b93ce7f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_893c4d566bf7c23131a27e81173533d7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bae740a1881b8d9dc02e32f36a50decc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b686e2c49e96535bc6856c67e286f4aa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ff7fef165c4e049bd84b8ae6bd4ed47 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fcaffe73350a3444935763c89f6cd4e2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_01b78afe135a598a144439c592ed9fd6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_95414a47d928e2c42043adb245a2548b
date	2021-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC8050996 https://pubmed.ncbi.nlm.nih.gov/33863383 https://doi.org/10.1186/s13287-021-02246-4
isPartOf	https://portal.issn.org/resource/ISSN/1757-6512 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37608
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/
title	A novel MSC-based immune induction strategy for ABO-incompatible liver transplantation: a phase I/II randomized, open-label, controlled trial
discusses	http://id.nlm.nih.gov/mesh/M0244307 http://id.nlm.nih.gov/mesh/M0000017
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9975 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8948

Total number of triples: 55.